advertisement

---

Your Special Attention For IGR 3-2

Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva

Broadway DC, Chang LP
Journal of Glaucoma 2001; 10: 237-249
No abstract in IGR

"Nice overview of trabeculectomy results with emphasis on mechanisms of failure and conjunctival state. Different types of glaucoma, race, and medical treatment effects"

---

Visual function assessment questionnaires

Massof RW, Rubin GS
Survey of Ophthalmology 2001; 45: 531-548

Abstract No. 369

---

"Questions about glaucoma and daily life. Validity and reliability are discussed. Comparison of major questionnaires"

---

Alzheimer's disease: a review for the ophthalmologist

Holroyd S, Shepherd ML
Survey of Ophthalmology 2001; 45: 516-524

Abstract No. 644

---

"Review of most prevalent dementia. Food for thought"

---

Complementary and alternative medicine for glaucoma

Rhee DJ, Katz J, Spaeth GL, Myers JS
Survey of Ophthalmology 2001; 46: 43-55

Abstract No. 580

---

"From Marihuana to Ginkgo Biloba. A few well designed studies"

---

Neuroprotection in perspective

Survey of Ophthalmology 2001; 45: supplement 3
No abstract in IGR

"Proceedings of a neuroprotection expert meeting in 2000. Memantine"

---

The PROCTOR Lecture:

A new approach to the medical management of glaucoma, from the bench to clinic and beyond

Bito LZ
No abstract in IGR

From PGF₂a-isopropyl ester to latanoprost: a review of the development of Xalatan

Stjernschantz JW
Investigative Ophthalmology & Visual Science 2001; 42: 1126-133, 1134-1145
No abstract in IGR

"The Bito-Stjernschantz Lecture on the development of latanoprost. The ups and downs of long-term scientific perseverance"

---